Price · last 3 months · daily close
CF price
Loading the price chart...
Daily closing prices via yfinance. Quotes are delayed. Past prices are not a guarantee of future results.
ValeriusBeta - Not investment advice
Research · S&P 500 · Materials
The numbers, the scorecard and what analysts say, with the source for each. Information, not advice.
Price · last 3 months · daily close
Loading the price chart...
Daily closing prices via yfinance. Quotes are delayed. Past prices are not a guarantee of future results.
Value Scorecard · run 2026-10-18
Earnings & returns
Diluted EPS: $16.38 (2022), $7.87 (2023), $6.74 (2024), $8.97 (2025). It ended at or below 2022; the framework scores that as 2.
ROE (net income / common equity): 66.2% (2022), 26.7% (2023), 24.4% (2024), 30.1% (2025). Median 28.4%, lowest 24.4%; the framework scores a median above 20% as 5.
ROIC of 17.4%: operating income of $2.30B divided by $13.20B of capital (total assets $14.09B minus current liabilities $887.00M), fiscal year to Dec 31, 2025, as filed in the 10-K (SEC EDGAR). The framework scores 15-20% as 4.
Net margin of 27.1%; the framework scores above 20% as 5; gross margin 42.5%, operating margin 49.3%.
Balance sheet & cash
Debt-to-equity of 0.41; the framework scores 0.3-0.8 as 4 (total debt $3.61B, total cash $2.48B).
Free cash flow (operating cash flow minus capital expenditure): $3.39B (2022), $1.03B (2023), $1.75B (2024), $1.80B (2025). It ended at or below 2022; the framework scores that as 2.
Retained earnings, as filed in the 10-Ks (SEC EDGAR): $3.87B (2022), $4.54B (2023), $4.01B (2024), $3.87B (2025). It ended above 2022 but did not rise in 2 of 3 years; the framework scores that as 3.
Valuation models
IV = EPS x (8.5 + 2g) x (4.4 / Y) = $13.48 x (8.5 + 2 x 6.8) x (4.4 / 4.5) = $291.29. Current price $120.85; price is 58.5% below the model value.
FCF/share = $8.436, stage 1 growth = 3.4% for 5 years, terminal growth = 3%, discount rate = 10%. Stage 1 PV = $35.17, PV of terminal value = $91.10, DCF value = $126.27. Current price $120.85; price is 4.3% below the model value.
Graham value $291.29 (price is 58.5% below the model value); DCF value $126.27 (price is 4.3% below the model value).
P/B of 3.19; the framework scores 3.0-5.0 as 2.
Business quality
A moat (a brand, a network, switching costs, patents, scale, a licence) is not a number in the filings, so Valerius doesn’t score it. Below are the figures and the words moat analysis starts from, from the company’s own 10-K filings. The conclusion is yours.
Return on capital, each year
Above 15% in 4 of 10 years (2016-2025); lowest 1.0%, highest 43.8%.
Gross margin, each year
Between 10.5% and 52.4% over 10 years (a range of 41.9 points).
Competition, in the company’s own words · 10-K filed Feb 25, 2026
Our markets are global and intensely competitive, based primarily on delivered price and, to a lesser extent, on low-carbon attributes, reliability, customer service and product quality. During the peak demand periods, product availability and delivery time also play a role in the buying decisions of customers. Our primary competitors with North American operations include Nutrien Ltd., Koch Fertilizer LLC, LSB Industries, CVR Partners, LP and Yara International. There is also significant competition from products sourced from other regions of the world, including some with lower natural gas or other feedstock costs, which may include the benefit of government subsidies. Because ammonia, urea and UAN are widely-traded fertilizer products and there are limited barriers to entry, we experience
The opening of the company’s “Competition” section in its 10-K, quoted word for word, not summarized or edited. It is the company’s own description, not Valerius’s view, and may include the company’s expectations. Open the filing.
Return on capital = operating income / (total assets − current liabilities), the ROIC row’s definition; 15% is the framework’s return threshold. Gross margin = gross profit / revenue. Both from each year’s 10-K via SEC EDGAR. Moat analysis commonly looks at whether returns and margins held up over many years. These figures don’t say whether the company has an advantage, what it is, or whether it will last.
Capital allocation, 2022-2025: dividends or buybacks paid in every year (pass); $6.19B paid out against $7.98B of free cash flow (pass); total debt $3.23B to $3.64B, up 12.7%, 1.1x EBITDA (pass: at most 2x EBITDA); shares outstanding 0.20B to 0.15B, down 21.5% (pass). 4 of 4 tests passed; the framework scores that as 5.
Filings
Three kinds of event the company reported to the SEC in the last 5 years, from its filings on SEC EDGAR.
Loading...
These are events the company reported to the SEC. An auditor change or a late filing can have many causes; each date links to the filing, where the company explains it. Valerius does not score these.
Graham Formula:
IV = EPS x (8.5 + 2g) x (4.4 / Y)
EPS = $13.48, g = 6.8%, Y = 4.5
IV = $291.29
Current price $120.85 vs Graham value $291.29 — price is 58.5% below the model value.
DCF:
FCF/share = $8.436
Stage 1 growth = 3.4% for 5 years | terminal growth = 3.0% | discount rate = 10.0%
Y1: $8.723 → PV $7.930
Y2: $9.020 → PV $7.454
Y3: $9.327 → PV $7.007
Y4: $9.644 → PV $6.587
Y5: $9.971 → PV $6.192
Stage 1 PV sum = $35.17
Terminal value at end of Y5 = $146.72
PV of terminal value = $91.10
DCF value = $126.27
Current price $120.85 vs DCF value $126.27 — price is 4.3% below the model value.Data from yfinance summary figures and financial statements, and from the company’s 10-K filings via SEC EDGAR; computed at a price of $120.85. Every score is calculated from the figures by the framework’s fixed rules, and the explanation beside it is generated from the same figures: Graham value, DCF value, margin of safety, ROIC, profit margins, debt-to-equity, price-to-book, EPS trend, ROE trend, free cash flow, retained earnings and capital allocation. No AI is involved in this scorecard. The moat is shown as evidence, without a score. Read each score with the figures beside it. Intrinsic value calculations are model outputs based on stated assumptions, not predictions.
Recent headlines · third-party publishers · not investment advice
The 8 newest headlines whose title names the company, shown automatically and never chosen by Valerius. From third-party publishers via Yahoo Finance, linked to the source. Valerius doesn't write or endorse them. Not investment advice.